Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Ordinary Shares, nominal value Euro 0.04 per share
-
Shares outstanding
-
105,365,368
-
Number of holders
-
26
-
Total 13F shares, excl. options
-
9,151,395
-
Shares change
-
-480,705
-
Total reported value, excl. options
-
$44,281,000
-
Value change
-
-$2,331,016
-
Number of buys
-
10
-
Number of sells
-
-16
-
Price
-
$4.84
Significant Holders of ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share (PRQR) as of Q2 2016
32 filings reported holding PRQR - ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share as of Q2 2016.
ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share (PRQR) has 26 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9,151,395 shares
of 105,365,368 outstanding shares and own 8.69% of the company stock.
Largest 10 shareholders include JENNISON ASSOCIATES LLC (2,672,377 shares), ORBIMED ADVISORS LLC (2,305,446 shares), BAKER BROS. ADVISORS LP (1,234,095 shares), Redmile Group, LLC (581,638 shares), Clearbridge Investments, LLC (504,279 shares), JANUS CAPITAL MANAGEMENT LLC (411,983 shares), FRANKLIN RESOURCES INC (309,700 shares), FMR LLC (237,916 shares), ALTRINSIC GLOBAL ADVISORS LLC (205,000 shares), and MILLENNIUM MANAGEMENT LLC (187,866 shares).
This table shows the top 26 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.